Recent News

• 09.02.2025 - CORMEDIX COMPLETES ACQUISITION OF MELINTA THERAPEUTICS, RAISES FINANCIAL GUIDANCE AND ANNOUNCES NEW LEADERSHIP TEAM
• 08.28.2025 - CORMEDIX TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
• 08.07.2025 - CORMEDIX TO ACQUIRE MELINTA THERAPEUTICS, CREATING DIVERSIFIED SPECIALTY COMPANY WITH STRONG PRESENCE IN ACUTE CARE SETTINGS
• 08.07.2025 - CORMEDIX INC. REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
• 06.27.2025 - CORMEDIX INC. ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK
• 06.23.2025 - CORMEDIX INC. ANNOUNCES CUSTOMER IMPLEMENTATION

Recent Filings

• 09.02.2025 - 8-K Current report
• 09.02.2025 - EX-99.1 EX-99.1
• 08.12.2025 - 8-K Current report
• 08.08.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.07.2025 - EX-99.1 EX-99.1
• 08.07.2025 - 8-K Current report
• 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 06.30.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 06.30.2025 - 8-K Current report
• 06.30.2025 - EX-99.1 EX-99.1